OTC · PJET
Priority Aviation, Inc.
$0.00$0.00 (0.0%)
Priority Aviation, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
Loading market information…
OTC · AMHD · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
HLK Biotech Holding Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.46% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
HLK Biotech Holding Group, Inc. operates primarily through its various subsidiaries, focusing on the production and distribution of biodiesel. In addition to its energy sector activities, the company also engages in the acquisition of real estate assets. The firm was formerly recognized as Amelot Holdings, Inc., but it officially rebranded to HLK Biotech Holding Group, Inc. in February 2018. The company's principal office is located in Norfolk, Virginia.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:33 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.00$0.00 (0.0%)
Priority Aviation, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
Millennium Sustainable Ventures Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
$0.00$0.00 (0.0%)
DMK Pharmaceuticals Corporation’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
eFFECTOR Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
$0.00$0.00 (0.0%)
BioELife Corp.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.00$0.00 (0.0%)
Micro Imaging Technology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 0.99% below the high.
$0.00$0.00 (0.0%)
Ingen Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
Minerva Surgical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
